Mavenclad Quickly Reduces MRI Lesions in Early MS, ORACLE-MS Data Show

Retrieved on: 2021-03-18 13:10:47

Tags for this article:

Multiple sclerosis

Neurological disorders

Nervous system

Organ systems

Cladribine

Clinically isolated syndrome

Magnetic resonance imaging

Tumefactive multiple sclerosis

Multiple sclerosis research

Click the tags to see associated articles and topics

Mavenclad Quickly Reduces MRI Lesions in Early MS, ORACLE-MS Data Show. View article details on hiswai:

Excerpt

One such trial, a Phase 3 study called ORACLE-MS (NCT00725985), showed that taking Mavenclad after a first clinical demyelinating event lowered the ...

Article found on: multiplesclerosisnewstoday.com

View Original Article